United Arab Emirates
· Delayed Price · Currency is AED DFM:NIH Statistics
Total Valuation
DFM:NIH has a market cap or net worth of AED 406.42 million. The enterprise value is 482.90 million.
| Market Cap | 406.42M |
| Enterprise Value | 482.90M |
Important Dates
The last earnings date was Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | Jul 9, 2024 |
Share Statistics
| Current Share Class | 231.73M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.55% |
| Shares Change (QoQ) | -0.79% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 145.51M |
Valuation Ratios
The trailing PE ratio is 18.56.
| PE Ratio | 18.56 |
| Forward PE | n/a |
| PS Ratio | 4.08 |
| PB Ratio | 0.70 |
| P/TBV Ratio | 0.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.10, with an EV/FCF ratio of -32.57.
| EV / Earnings | 22.05 |
| EV / Sales | 4.83 |
| EV / EBITDA | 10.10 |
| EV / EBIT | 10.59 |
| EV / FCF | -32.57 |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.18 |
| Quick Ratio | 2.01 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.59 |
| Debt / FCF | -1.90 |
| Interest Coverage | 19.10 |
Financial Efficiency
Return on equity (ROE) is 4.36% and return on invested capital (ROIC) is 4.74%.
| Return on Equity (ROE) | 4.36% |
| Return on Assets (ROA) | 4.32% |
| Return on Invested Capital (ROIC) | 4.74% |
| Return on Capital Employed (ROCE) | 7.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.15 |
| Inventory Turnover | 3.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.33% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +21.33% |
| 50-Day Moving Average | 2.22 |
| 200-Day Moving Average | 2.63 |
| Relative Strength Index (RSI) | 38.95 |
| Average Volume (20 Days) | 25,208 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DFM:NIH had revenue of AED 99.53 million and earned 21.90 million in profits. Earnings per share was 0.10.
| Revenue | 99.53M |
| Gross Profit | 65.97M |
| Operating Income | 45.44M |
| Pretax Income | 24.99M |
| Net Income | 21.90M |
| EBITDA | 47.65M |
| EBIT | 45.44M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
The company has 57.80 million in cash and 28.18 million in debt, giving a net cash position of 29.61 million.
| Cash & Cash Equivalents | 57.80M |
| Total Debt | 28.18M |
| Net Cash | 29.61M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 577.07M |
| Book Value Per Share | 2.05 |
| Working Capital | 68.60M |
Cash Flow
In the last 12 months, operating cash flow was -13.77 million and capital expenditures -1.06 million, giving a free cash flow of -14.83 million.
| Operating Cash Flow | -13.77M |
| Capital Expenditures | -1.06M |
| Free Cash Flow | -14.83M |
| FCF Per Share | n/a |
Margins
Gross margin is 66.28%, with operating and profit margins of 45.66% and 22.00%.
| Gross Margin | 66.28% |
| Operating Margin | 45.66% |
| Pretax Margin | 25.11% |
| Profit Margin | 22.00% |
| EBITDA Margin | 47.88% |
| EBIT Margin | 45.66% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 3.95%.
| Dividend Per Share | 0.07 |
| Dividend Yield | 3.95% |
| Dividend Growth (YoY) | 20.31% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 71.79% |
| Buyback Yield | 0.55% |
| Shareholder Yield | 4.50% |
| Earnings Yield | 5.39% |
| FCF Yield | -3.65% |
Stock Splits
The last stock split was on July 19, 2022. It was a forward split with a ratio of 1.03.
| Last Split Date | Jul 19, 2022 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |